Sensitivity analysis of ICER estimates for QALYs gained in community-based therapy of S. haematobium.

Shown are the 11 most influential inputs to the model and the effects of their variation on $US cost per lifetime QALY gained when calculating the incremental cost effectiveness of single-dose vs. double-dose treatment regimens in community-based programs. The base case analysis from Table 4 is indicated by the vertical dotted line.